Regeneus Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Regeneus Ltd with three other
pharmaceutical manufacturers in Australasia:
Prescient Therapeutics Ltd
(2019
sales of 72,109.00 Australian Dollars [US$42,973.36 ]
),
Genetic Technologies Limited
(25,444.00 Australian Dollars [US$15,163.35 ]
of which 100%
was Operations), and
ECS Botanics Holdings Ltd
(1,384.00 Australian Dollars [US$824.79 ]
).
Sales Analysis.
Sales fell dramatically in 2019:
Regeneus Ltd reported sales of A$25,077.00 (US$14.94 thousand)
for the
fiscal
year ending
June of 2019.
This
represents
a
sharp
decrease of 95.9%
versus 2018, when the company's sales were A$610,511.00 .